MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Laboratory Investigation
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

386 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
386 works in the cohort · of 4,299,418page 2 of 8

Labels cover 1 of 386 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 386 of 386 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundno abstractunlabeled
Versican: a novel modulator of hepatic fibrosis
Terence N. Bukong, Sean B Maurice, Barinder Chahal, David F. Schaeffer, Paul Winwood
2016· article· en· Laboratory Investigation· Medicine
machine prediction:candidate · noneconsensus · none
65
citations
affno abstractunlabeled
DNA methylation of HOXD3 as a marker of prostate cancer progression
Ken J. Kron, Liyang Liu, Vaijayanti Pethe, Nino Demetrashvili, Michael Nesbitt, John Trachtenberg +5 more
2010· article· en· Laboratory Investigation· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
59
citations
afffundno abstractunlabeled
Fibulin-5 functions as an endogenous angiogenesis inhibitor
Kaitlyn Sullivan, Rachel Bissonnette, Hiromi Yanagisawa, Sabah N. A. Hussain, Elaine C. Davis
2007· article· en· Laboratory Investigation· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
57
citations
affno abstractunlabeled
NOD2: a potential target for regulating liver injury
Mathilde Body–Malapel, Sébastien Dharancy, Dominique Berrebi, Alexandre Louvet, Jean‐Pierre Hugot, Dana J. Philpott +13 more
2008· article· en· Laboratory Investigation· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
52
citations

How this was built: Screen · Findings · About